title: Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity.
abstract: Drug allergy refers to a hypersensitivity reaction for which either an IgE or T-cell-mediated mechanism is demonstrated. The recognition of the drug by B and T cells is influenced by variants of HLA genes. The genetic factors involved in IgE-mediated mechanisms have been studied mainly in beta-lactam reactions, and they appear to be related to human leukocyte antigen presentation (HLA A2 and DRw52), TNFA -308G>A, class switching to IgE by B cells (variants of IL-13 and of IL-4RA), and expression of IgE receptors on target cells (variant of the FcepsilonRIbeta gene). Delayed T-cell-mediated reactions are also associated with HLA alleles. Studies have reported an association of HLA-B*1502 and HLA-B*5801 in patients with the Stevens-Johnson syndrome or toxic epidermal necrolysis provoked by carbamazepine, as well as of HLA-B*5701 with abacavir hypersensitivity. HLA-B*5701 seems to be a strong predictor in whites, but not in Hispanics or Africans. Carbamazepine hypersensitivity is also influenced by gene variants of cytochrome P450 enzymes on the generation of reactive metabolites, while CYP2C9*2 and CYP2C9*3 polymorphisms influence the bioactivation of sulfamethoxazole in prohapten. Pharmacogenetic studies on aspirin hypersensitivity have identified distinct types of predictors, such as HLA genotypes, a polymorphism in the promoter of the FcepsilonRIalpha gene, and variants in genes of enzymes from the arachidonic acid pathway. In the future, identification of genetic predictors will benefit from genomewide association studies that also take ethnic differences into account. Ideally, predictors will help to prevent adverse reactions, as suggested by a recent study on the effectiveness of prospective HLA-B*5701 screening to prevent hypersensitivity reactions to abacavir in HIV patients.
authors.affiliation: INSERM U-724, Cellular and Molecular Pathology in Nutrition, Faculty of Medicine, University Henry Poincaré and University Hospital Center of Nancy, Vandoeuvre lès Nancy, France. Jean-Louis.Gueant@medecine.uhp-nancy.fr
authors.forename: J L
authors.initials: JL
authors.lastname: Guéant
authors.forename: R M
authors.initials: RM
authors.lastname: Guéant-Rodriguez
authors.forename: I Aimone
authors.initials: IA
authors.lastname: Gastin
authors.forename: J A
authors.initials: JA
authors.lastname: Cornejo-García
authors.forename: M
authors.initials: M
authors.lastname: Viola
authors.forename: A
authors.initials: A
authors.lastname: Barbaud
authors.forename: P M
authors.initials: PM
authors.lastname: Mertes
authors.forename: M
authors.initials: M
authors.lastname: Blanca
authors.forename: A
authors.initials: A
authors.lastname: Romano
mesh_terms: D000818:Animals; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology; D006969:Hypersensitivity, Immediate / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology; D010597:Pharmacogenetics / Q000379:methods*